Treatment for Respiratory Bronchiolitis
Treatment for respiratory bronchiolitis must be tailored to the specific underlying cause: for infectious bacterial bronchiolitis, prolonged antibiotic therapy is recommended; for toxic/antigenic exposure or drug-related bronchiolitis, immediate cessation of the exposure or medication plus corticosteroid therapy for those with physiologic impairment is the appropriate approach 1.
Diagnostic Workup Required Before Treatment
Before initiating treatment, you need to establish the specific etiology of bronchiolitis through:
- Comprehensive medical history focusing on exposures (occupational, environmental, drugs) and underlying systemic diseases
- Spirometry with and without bronchodilator, lung volumes, and gas exchange testing
- HRCT chest with expiratory cuts looking for:
- Direct signs: airway wall thickening, nodular branching (2-4 mm), "tree-in-bud" pattern
- Indirect signs: mosaic attenuation on expiration (air-trapping), subsegmental atelectasis
- Bronchoscopy to rule out infection and assess for purulent secretions (required before excluding bacterial suppurative disease) 1
Important caveat: Normal chest radiograph and even normal HRCT do not rule out bronchiolar disease, as airways <2 mm cannot be visualized. In cryptogenic bronchiolitis obliterans, HRCT may show only indirect features 1.
Treatment Algorithm by Etiology
1. Infectious Bacterial Bronchiolitis
- Prolonged antibiotic therapy (specific duration not defined in guidelines, but "prolonged" implies weeks rather than days)
- This improves cough and is strongly recommended 1
2. Toxic/Antigenic Exposure or Drug-Related Bronchiolitis
- Immediate cessation of the offending exposure or medication
- Corticosteroid therapy for patients with physiologic impairment on pulmonary function testing
- Do not use corticosteroids in those without documented physiologic impairment 1
3. When Diagnosis Remains Uncertain
Surgical lung biopsy is indicated when the combination of clinical syndrome, physiology, and HRCT findings do not provide a confident diagnosis. This provides pathologic classification necessary for targeted therapy 1.
Key Clinical Pitfalls
Do not confuse respiratory bronchiolitis (adult small airways disease) with acute viral bronchiolitis in infants - the latter is a completely different entity requiring only supportive care 2, 3. The evidence provided about viral bronchiolitis in infants (references 2-9) is not applicable to adult respiratory bronchiolitis.
Bronchoscopy is mandatory before excluding bacterial suppurative airways disease as a cause, even when other common causes of cough have been excluded, because bacterial disease may be clinically unsuspected 1.
The underlying principle is that respiratory bronchiolitis represents a heterogeneous group of disorders affecting small airways, and effective treatment depends entirely on identifying and addressing the specific etiology rather than applying generic therapy 1.